developer, editor
60,576
edits
Changes
Jump to navigation
Jump to search
Novartis combined its agricultural division with that of AstraZeneca to create Syngenta in November 2000. In 2003, Novartis created a new company named Sandoz, a subsidiary that bundles its generic drug production, reusing the predecessor brand. On 20 April 2006, Novartis acquired the California-based Chiron Corporation. Chiron was formerly divided into three units: Chiron Vaccines and Chiron Blood Testing, which now combine to form Novartis Vaccines and Diagnostics, and Chiron BioPharmaceuticals, to be integrated into Novartis Pharmaceuticals. The ongoing Basel Campus Project has the aim to transform the St. Johann site - Novartis headquarters in Basel - "from an industrial complex to a place of innovation, knowledge and encounter".[11] In 2005, Novartis introduced Certican (Everolimus), an immunosuppressant, and in October 2006 began marketing Telbivudine, a new antiviral drug for hepatitis B." Historical overview taken from:<ref>[http://www.fundinguniverseallbusiness.com/company-historiesactivities-management/Novartiscompany-AGstructures-Companyownership/5392342-History1.html "Chiron Shareholders Approve Novartis Company HistoryAcquisition"]</ref> and <ref>[http://en.wikipedia, ''Media Release'', April 19 2006.org/wiki/Novartis#cite_note-2 "Wikipedia article on Novartis"]</ref>
SW: →Company History: add full refs, cull kess useful material
Novartis was founded in 1996 as a result of the merger of Ciba-Geigy and Sandoz, both Swiss companies with a long history of pharmaceutical experience.<ref>Novartis, [http://www.novartis.com/about-novartis/company-history/index.shtml "Novartis History"], Novartis website, accessed December 2008.</ref> Following the merger, Novartis reorganized its activities, and spun out its chemicals activities as Ciba Specialty Chemicals, which, in January 1997, became an independent company.<ref>Ciba, [http://cibasc.com/index/cmp-index/cmp-about.htm "About Us"], Ciba website, accessed December 2008.</ref> {In September 2008 BASF bought Ciba).<ref>[http://www.corporate.basf.com/en/presse/mitteilungen/pm.htm?pmid=3229&id=V00-qN3bGDLaUbcp*WJ "BASF makes offer to acquire Ciba"], Media Release, September 15, 2008.</ref><ref>[http://www.iht.com/articles/2008/09/15/business/basf.php "BASF buys Swiss specialty chemicals maker Ciba"], ''International Herald Tribune'', September 15, 2008.</ref>
Novartis combined its agricultural division with that of [[AstraZeneca]] to create [[Syngenta]] in November 2000.<ref>Syngenta, [http://www.syngenta.com/en/about_syngenta/companyhistory.html "Company History"], Syngenta website, accessed December 2008.</ref>
In 1998 the 2003, Novartis created a new company made headlines with named Sandoz, a subsidiary that bundles its biotechnology licensing agreement with generic drug production, reusing the UC Berkeley Department of Plant and Microbial Biologypredecessor brand.<ref>Sandoz, [http://www.sandoz.it/site/it/l_azienda/News/Notizie/pool/Novartis_toSandoz. Critics pdf "Return of the agreement expressed concern over prospects that the agreement would diminish academic objectivitya traditional name: Novartis Generics rebranded as Sandoz"], Media Release, May 20, or lead to the commercialization of genetically modified plants. The agreement expired in 2003.</ref>
==Financial Highlights==
